← Archive
IN FORCE Advance Authorisation

DGFT Minutes

Reliability

In force — no superseding record on file.

Document text

‘o> aetira waa Governmentof India / HRd GbR Ministry of Commerce and Industry / @fSUwY 3h Fahy Aareays Department of Commerce / fours fSqyr Directorate General of Foreign Trade, Delhi / Sexi GOR Heloaeanag, Pavel VANIJYA BHAWAN, AKBAR ROAD, CENTRAL DELHI, DELHI, 110011 / aIfS0rea Hat, separ Us, ag Baeeh Email Office : dgft@nic.in , Phone Office : 011-23062777

Meeting No - NC/3/MEET/Feb/202223/20

Meeting Date - 24/02/2023

Minutes of the Norms Committee — 3 Meeting No. NC/3/MEET/Feb/202223/20 dated 24/02/2023 (actually held on 03/03/2023) under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30.

Following members were present in the Meeting:

==> picture [388 x 56] intentionally omitted <==

----- Start of picture text -----<br>

||||||||
|---|---|---|---|---|---|---|
|Shri|Nand|Lal,|Technical|—|3|Consultant|
|In|attendance|:|
|EY|SS|is]|Shri Ajay Kumar, Deputy|Director|DGFT|

----- End of picture text -----<br>

Be The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirementsas prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.

S The committee went through the Minutes of earlier Meeting No. NC/3/MEET/Feb/202223/21 dated 22/02/2023.

SVT BAX / AJAY KUMAR ST TERS /Deputy Director aiersa fee = 5) : pes Bes ie : Udyog Bhawan, Now fon \“ \03

MANUAL CASES

==> picture [469 x 251] intentionally omitted <==

----- Start of picture text -----<br> Case No. A-01 oe<br>Meeting No. NC/3/MEET/Feb/202223/20<br>ee et eee i<br>Mis Indo Amines Limited<br>HQ F. No. 0.1/82/162/00011/AM23/DES-III [P- 34974]<br>RLA F. No. 03/82/040/00013/AM20<br>Advance Authorization No. and Date 0310829430 dated 06/06/2019<br>Subject Request of M/s Indo Amines Limited for inclusion of additional<br>export products in respect of Advance Authorization No.<br>0310829430 dated 06/06/2019<br>Decision: | The Committee considered the request of firm for review of adhoc norms and it was decided to revise<br>adhoc norms as under:<br>Sl. Export Product Qty. | Sl. | Import Items Qty.<br>No. No.<br>jl |BenzylAmineNN | kg 1 | Benzaldehyde 1.06 kg<br>Dimethyl Benzyl Amine |1kg| 1 | Benzaldehyde 1.06 kg<br>Di Benzyl Amine I Benzaldehyde 1.30 kg<br>RA concerned may take further necessary action as per above decision of NC.<br>Note: The above norms are only for regularization purpose and no repeat licences will be issued on the<br>basis of these norms.<br>----- End of picture text -----<br>

==> picture [473 x 263] intentionally omitted <==

ly for regularization purpose and no repeat licences will be issued on the<br>basis of these norms.<br>----- End of picture text -----<br>

==> picture [473 x 263] intentionally omitted <==

----- Start of picture text -----<br> SS a eeeSSeee! 6<br>NC/3/MEET/Feb/202223/20<br>M/s Indo Amines Limited<br>HQ F. No. 01/82/050/00175/AM19/DES-II]<br>RLA F. No. 03/94/040/00869/AM18<br>Advance Authorization No. and Date 0310819353 dated 22/02/2018<br>Subject Request of M/s Indo Amines Limited for inclusion of additional<br>export products in respect of Advance Authorization No.<br>0310819353 dated 22/02/2018<br>Decision: |The Committee considered the request of firm for review of adhoc norms and it was decided to revise<br>adhoc norms as under:<br>Sl. | Export Product Qty. | Sl. | Import Items Qty.<br>| 1No.| TallowTallo Amine (IAL TA) |ikg|1No.| C 1618 Fatty Acid 1.60 kg<br> Amine Distilled (IAL TAD) |1kg| 1 | C 16 18 Fatty Acid 1.63 kg<br>Stearyl Amines 100 (IAL SA 100) |[kg| 1 | C 16 18 Fatty Acid 1.80 kg<br>RA concerned may take further necessary action as per above decision of NC.<br>Note: The above norms are only for regularization purpose and no repeat licences will be issued on the<br>basis of these norms.<br>----- End of picture text -----<br>

r above decision of NC.<br>Note: The above norms are only for regularization purpose and no repeat licences will be issued on the<br>basis of these norms.<br>----- End of picture text -----<br>

|A-03|
|---|
|NC/3/MEET/Feb/202223/20<br>i|
|24/02/2023<br>[Firm’sName<br>S_—s|sMiis Aarti Drugs Ltd,<br>Subject<br>Request of M/s Arti Drugs for review of adhoc norms fixed against<br>ee<br>ee|
|Sl. |Hqrs. F.No.<br>RLA F. No.<br>Advance<br>Advance|
|No<br>Authorization |Authorization|
||_| HQRNORMAPPL Y00100557AM22 | 03AA04029700AM21_| 0311002516 | 27-05-2021_|
|6 | HORNORMAPPL Y00106682AM22 |03AA04021320AM22 | 0311004283 | 03-06-2021|
|[8_|HORNORMAPPLY00107444AM22<br>| 03AA04021339AM22 |0311004322 |04-06-2021<br>-9__| HQRNORMAPPLY00112663AM22 **|** **03A**4A0402242**7AM22**_**|** 0311004537 **|** 11**-06-2021**<br>(10|HORNORMAPPLY001 0846AM2<br>A0402871<br>0311004808<br>22|
|**0**5**-0**8-202<br>|14 | HQRNORMAPPL Y00157208AM22 |03AA04061662AM22_|<br>0311006047 |<br>9 8-2021|
||16 | HQRNORMAPPL Y00168069AM22 |03AA04065122AM22_| 0311006313 | 21-08-2021_||
||18|HORNORMAPPLY00169932AM22<br>**|** **03AA040**6929**0AM22**_**|** **0311006**414| **2**4-08-20**2**1_<br>[19|HORNORMAPPLY00173288AM2<br>_<br>7448<br>526 | 9-08-2021|
|23-10-2020_|

-2021_|| ||18|HORNORMAPPLY00169932AM22<br>| 03AA04069290AM22| 0311006414| 24-08-2021<br>[19|HORNORMAPPLY00173288AM2<br><br>7448<br>526 | 9-08-2021| |23-10-2020|




```text
|039404000346AM21|
|---|
|05-11-2020|
|21-01-2021|
||46 |HQRNORMAPPL Y00067217AM21 |03AA04019654AM21_|<br>031**1**001138|21-01-2021 |<br>(48 [HORNORMAPPLY000682 9AM21<br>|03AA04020020AM21 [031**1**001191 **|** **2**9**-01-**3**0**9**1** **|**<br>|49 | HQRNORMAPPL Y00069628AM21 |03AA04020216AM21_|<br>03 1001225<br>5<br>2 2|
|(60 | HQRNORMAPPL Y00003031AM22 |039404000229AM21 | 0311003737|05-04-2021<br>[61 | HORNORMAPPL Y00003027AM22_| 03AA04031763AM21 | 0311002768 | 05-04-0031|
|66 | HQRNORMAPPL Y00300612AM22 |03AX04000458AM22_|<br>0311009880 | 29-12-2021|
||68 | HQRNORMAPPL Y00301808AM22 |03AX04000439AM22_|<br>**03110099**08**|**30**-**12**-202**1<br>|69|HORNORMAPPLY00305699AM22|03AA040128756AM22|<br>97<br>0301<br>2|

SSH WA / AJAY KUMAR wy Feet / Deputy Sector

Decision: As per the decision taken by the Committee in its Meeting No. NC/3/MEET/Nov/202223/13 dated 24/11/2022, the factory visit of M/s Aarti Drugs Limited was carried out on 04.02.2023 under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT to ascertain the exact wastage of import items in their licences.

The Committee examined the Factory Visit Report and after deliberation, it was decided to revise adhoc norms as under:

, Jt. DGFT to ascertain the exact wastage of import items in their licences.

The Committee examined the Factory Visit Report and after deliberation, it was decided to revise adhoc norms as under:

No. Ciprofloxacin Hydrochloride Ethyl 3 Cyclopropylamino-2(2.4 Dichloro- | 1.294 kg BP/EP/USP (Ciprofloxacin) 5Fluorobenzoyl) Acrylate Piperazine Anhydrous 0.390 kg RA concerned may take further necessary action as per above decision of NC. Note: The above norms are only for regularization purpose and no repeat licences will be issued on the basis of these norms.

Meeting ended with thanks to Chair and participants ae Eooe a

==> picture [228 x 33] intentionally omitted <==

----- Start of picture text -----<br> BR gine<br>SSS_ SYHATPes / /DsputyAJAYDirector KUMAR \nfo3<br>----- End of picture text -----<br>

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 8005 --apply.

Citation copied